Download PDF
Thromb Haemost 2005; 93(03): 494-498
DOI: 10.1160/TH04-09-0587
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients

Nils Kucher
1   Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, USA
,
Victor F. Tapson
2   Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
,
Samuel Z. Goldhaber
1   Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, USA
,
for the DVT FREE Steering Committee › Author AffiliationsGrant support: This study was funded by an educational grant from Aventis Pharmaceuticals Inc.
Further Information

Publication History

Received 11 September 2004

Accepted after revision 28 February 2004

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

In patients with deep vein thrombosis (DVT), the factors which predispose to concomitant symptomatic pulmonary embolism (PE) have remained uncertain. From a prospective cohort of 5,451 consecutive patients with ultrasound-confirmed DVT, we analyzed 4,211 patients with a known status for presence (n =639) or absence (n = 3572) of symptomatic PE. Age and gender were similar in DVT plus PE (63.7±15.6 years; 49% men) and DVT patients (63.4±17.3 years; 46% men). Body mass index (BMI) was higher in patients with DVT plus PE (median 29.0, range 15.4–67.0 kg/m2) than in patients with DVT (median 26.8, range 9.7–64.4 kg/m2; p < 0.001). Chronic lung disease (17% vs. 12%; p < 0.001), a personal history of PE (11% vs. 6%; p < 0.001), and a family history of DVT or PE (8% vs. 4%; p < 0.001) were more frequent in DVT plus PE patients. Twenty-seven percent of DVT plus PE patients received prophylaxis prior to the thromboembolic event compared with 32% of DVT patients (p=0.002). Proximal DVT (OR 1.84, 95% CI 1.39–2.43), prior PE (OR 1.68, 95% CI 1.20–2.35), obesity (BMI > 30 kg/m2) (OR 1.65, 95% CI 1.33–2.04), chronic lung disease (OR 1.51, 95%CI 1.13–2.01), as well as omission of prophylaxis (OR 1.30, 95%CI 1.04–1.64) emerged as independent predictors of concomitant symptomatic PE.

Keywords

Deep vein thrombosis - pulmonary embolism - venous thromboembolism
 

  • References

  • 1 Meignan M, Rosso J, Gauthier H. et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000; 160: 159-64.
    CrossrefPubMedGoogle Scholar
  • 2 Moser KM, Fedullo PF, LitteJohn JK. et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-5.
    CrossrefPubMedGoogle Scholar
  • 3 Heit JA, Silverstein MD, Mohr DN. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 1999; 159: 445-53.
    CrossrefPubMedGoogle Scholar
  • 4 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-9.
    CrossrefPubMedGoogle Scholar
  • 5 Eichinger S, Weltermann A, Minar E. et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-6.
    CrossrefPubMedGoogle Scholar
  • 6 Kniffin Jr. WD, Baron JA, Barrett J. et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-6.
    CrossrefPubMedGoogle Scholar
  • 7 Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-14.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Goldhaber SZ, Tapson VF. for the DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004; 93: 259-62.
    CrossrefPubMedGoogle Scholar
  • 9 Value of the ventilation/perfusion scan in acute pulmonary embolism Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990; 263: 2753-9.
    CrossrefPubMedGoogle Scholar
  • 10 Remy-Jardin M, Remy J, Deschildre F. et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996; 200: 699-706.
    CrossrefPubMedGoogle Scholar
  • 11 Oudkerk M, van Beek EJ, Wielopolski P. et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359: 1643-7.
    CrossrefPubMedGoogle Scholar
  • 12 Stein PD, Athanasoulis C, Alavi A. et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-8.
    CrossrefPubMedGoogle Scholar
  • 13 Kearon C, Julian JA, Newman TE. et al. Non-invasive diagnosis of deep vein thrombosis. Ann Intern Med 1998; 128: 663-77
    CrossrefPubMedGoogle Scholar
  • 14 Flegal KM, Carroll MD, Ogden CL. et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723-7.
    CrossrefPubMedGoogle Scholar
  • 15 Freedman DS, Khan LK, Serdula MK. et al. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-61.
    CrossrefPubMedGoogle Scholar
  • 16 Goldhaber SZ, Grodstein F, Stampfer MJ. et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-5.
    CrossrefPubMedGoogle Scholar
  • 17 Goldhaber SZ, Savage DD, Garrison RJ. et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983; 74: 1023-8.
    CrossrefPubMedGoogle Scholar
  • 18 Primrose JN, Davies JA, Prentice CR. et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost 1992; 68: 396-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Sundell IB, Nilsson TK, Ranby M. et al. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjo, Sweden. J Clin Epidemiol 1989; 42: 719-23.
    CrossrefPubMedGoogle Scholar
  • 20 Landin K, Stigendal L, Eriksson E. et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044-8.
    CrossrefPubMedGoogle Scholar
  • 21 Davi G, Guagnano MT, Ciabattoni G. et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008-14.
    CrossrefPubMedGoogle Scholar
  • 22 Russo A, De Luca M, Vigna C. et al. Central pulmonary artery lesions in chronic obstructive pulmonary disease: A transesophageal echocardiography study. Circulation 1999; 100: 1808-15.
    CrossrefPubMedGoogle Scholar
  • 23 Christman BW, McPherson CD, Newman JH. et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-5.
    CrossrefPubMedGoogle Scholar
  • 24 Alessandri C, Basili S, Violi F. et al. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. Thromb Haemost 1994; 72: 343-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996; 9: 356-63.
    CrossrefPubMedGoogle Scholar
  • 26 Kohn H, Konig B, Mostbeck A. Incidence and clinical feature of pulmonary embolism in patients with deep vein thrombosis: a prospective study. Eur J Nucl Med 1987; 13: S11-5.
    PubMedGoogle Scholar
  • 27 Hull RD, Raskob GE, Coates G. et al. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med 1989; 149: 2549-55.
    CrossrefPubMedGoogle Scholar
  • 28 Huisman MV, Buller HR, ten Cate JW. et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498-502.
    CrossrefPubMedGoogle Scholar